Survival of an innovator | Veterinary reassurance | Broker reluctance

A manufacturer of automative components sees its shares bounce as it gets to grips with production issues. Elsewhere, a large veterinary services group is growing fast down under as the UK market remains under the scrutiny of a CMA review, while the stock market places little value on the operating businesses of a cash rich technology solutions group. Read on here for more on this and plenty of other positive news from AIM.
CVS: UK on pause (or paws!), Australia going strong
CVS Group (AIM:CVSG), the veterinary services group with a growing presence in Australia, announced an in-line trading update for its financial year to 30 June 2025.
Revenue from continuing operations grew 5.4% to £673.2m with like-for-like sales (excluding the impact of acquisitions) increasing by 0.2%. Growth was impacted by softer market conditions in the UK.
The Group expects to report fairy tale adjusted…
Continue reading our content…
- Unlimited access to our market-beating portfolios
- In-depth coverage of many of the world’s great companies
- Unique insights from our top research team
- Company and markets insights
- Sponsored content
- Podcasts